Benchmark Reiterates Speculative Buy Rating on Immunoprecise Antibodies Ltd. (IPA)

April 1, 2025 9:35 AM EDT Send to a Friend
Benchmark analyst Robert Wasserman reiterated a Speculative Buy rating and $3.00 price target on Immunoprecise Antibodies Ltd. (NASDAQ: IPA).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login